ifosfamide has been researched along with Edema in 7 studies
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide (IFS) is an antineoplastic alkylating agent whose major side effect is hemorrhagic cystitis (HC)." | 7.74 | Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis. ( Batista, CK; Brito, GA; Cunha, FQ; Leitão, BT; Mota, JM; Ribeiro, RA; Souza, MH; Souza, ML, 2007) |
| " Groups (N = 6-8) were submitted to right or left paw edema (PE) with carrageenan (100 microg) or Dextran (200 microg), hemorrhagic cystitis with ifosfamide (200 mg/kg, ip) or gastric injury (GI) with indomethacin (20 mg/kg, vo)." | 3.75 | Hind limb ischemic preconditioning induces an anti-inflammatory response by remote organs in rats. ( Gomes, AS; Loiola, RT; Ribeiro, RA; Rocha, EL; Simão, AF; Souza Filho, MV; Souza, MH, 2009) |
| "Ifosfamide (IFS) is an antineoplastic alkylating agent whose major side effect is hemorrhagic cystitis (HC)." | 3.74 | Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis. ( Batista, CK; Brito, GA; Cunha, FQ; Leitão, BT; Mota, JM; Ribeiro, RA; Souza, MH; Souza, ML, 2007) |
| "More recently, a number of cases of panniculitis and subcutaneous inflammatory oedema have been described." | 1.37 | [Severe skin reaction with mucous membrane inflammation during MINE chemotherapy]. ( Camus, M; Guillet, G; Hainaut-Wierzbicka, E; Levillain, P; Lopez, L; Saulnier, JP, 2011) |
| " Ifosfamide, although itself the effective antineoplastic drug useful in situations which have proved refractory to cyclophosphamide therapy, has the side-effect toxicities caused by its metabolities that pose clinically a very real problem." | 1.30 | Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide. ( Konarski, L; Kowalski, P; Kuśnierczyk, H; Radzikowski, C, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Souza Filho, MV | 1 |
| Loiola, RT | 1 |
| Rocha, EL | 1 |
| Simão, AF | 1 |
| Gomes, AS | 1 |
| Souza, MH | 2 |
| Ribeiro, RA | 3 |
| Camus, M | 1 |
| Hainaut-Wierzbicka, E | 1 |
| Levillain, P | 1 |
| Saulnier, JP | 1 |
| Lopez, L | 1 |
| Guillet, G | 1 |
| Wang, PL | 1 |
| Cheng, YB | 1 |
| Kuerban, G | 1 |
| Batista, CK | 1 |
| Mota, JM | 1 |
| Souza, ML | 1 |
| Leitão, BT | 1 |
| Brito, GA | 1 |
| Cunha, FQ | 1 |
| Lima, MV | 1 |
| Ferreira, FV | 1 |
| Macedo, FY | 1 |
| de Castro Brito, GA | 1 |
| Kuśnierczyk, H | 1 |
| Konarski, L | 1 |
| Kowalski, P | 1 |
| Radzikowski, C | 1 |
| Maubec, E | 1 |
| Oberlin, O | 1 |
| Belhadj, K | 1 |
| Roujeau, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Remote Ischemic Preconditioning on Restenosis Post Lower Limb Revascularization Angioplasty: A Pilot Randomized Control Trial[NCT02406131] | 40 participants (Anticipated) | Interventional | 2018-04-30 | Suspended (stopped due to logistic issues - no available scans for participants at the moment need to postponed starting dates) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ifosfamide and Edema
| Article | Year |
|---|---|
Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cysto | 2007 |
6 other studies available for ifosfamide and Edema
| Article | Year |
|---|---|
Hind limb ischemic preconditioning induces an anti-inflammatory response by remote organs in rats.
Topics: Acute Disease; Animals; Carrageenan; Cystitis; Edema; Hindlimb; Ifosfamide; Indomethacin; Inflammati | 2009 |
[Severe skin reaction with mucous membrane inflammation during MINE chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Edema; Etoposide; Female | 2011 |
The clinical characteristic differences between thrombosis-related edema and lymphedema following radiotherapy or chemoradiotherapy for patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy | 2012 |
Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
Topics: Acrolein; Amifostine; Animals; Antidotes; Antineoplastic Agents, Alkylating; Cystitis; Dose-Response | 2007 |
Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide.
Topics: Administration, Oral; Animals; Cystitis; Edema; Female; Hemorrhage; Ifosfamide; Injections, Intraper | 1997 |
[Subcutaneous inflammatory edema induced by MINE chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillary Leak Syndrome; Creatin | 2001 |